A detailed history of Optiver Holding B.V. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Optiver Holding B.V. holds 3,200 shares of SGMO stock, worth $6,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,200
Holding current value
$6,400
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.36 - $0.65 $1,152 - $2,080
3,200 New
3,200 $1,000
Q2 2022

Aug 10, 2022

SELL
$3.28 - $6.21 $4,729 - $8,954
-1,442 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$5.23 - $7.82 $4,210 - $6,295
805 Added 126.37%
1,442 $8,000
Q4 2021

Feb 14, 2022

BUY
$7.29 - $10.97 $4,643 - $6,987
637 New
637 $4,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $313M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.